Jazz Pharmaceuticals
JAZZ
#1750
Rank
โ‚น1.071 T
Marketcap
โ‚น17,401
Share price
1.48%
Change (1 day)
42.49%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -โ‚น60.21 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are โ‚น4.15 Billion. In 2024 the company made an earning of โ‚น44.23 Billion, an increase over its 2023 earnings that were of โ‚น28.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น60.21 Billion-236.08%
2024 โ‚น44.23 B57.87%
2023 โ‚น28.02 B-179.92%
2022 -โ‚น35.07 Billion230.37%
2021 -โ‚น10.62 Billion-141.02%
2020 โ‚น25.87 B-39.45%
2019 โ‚น42.72 B-14.2%
2018 โ‚น49.79 B20.03%
2017 โ‚น41.48 B-17.15%
2016 โ‚น50.07 B22.14%
2015 โ‚น41.00 B187.64%
2014 โ‚น14.25 B-50.79%
2013 โ‚น28.96 B73.63%
2012 โ‚น16.68 B41.69%
2011 โ‚น11.77 B116.61%
2010 โ‚น5.43 B262.77%
2009 โ‚น1.49 B-111.33%
2008 -โ‚น13.23 Billion1.31%
2007 -โ‚น13.06 Billion77.8%
2006 -โ‚น7.35 Billion36.59%
2005 -โ‚น5.38 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.537 T-2,425.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
โ‚น197.20 B-398.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-โ‚น224.97 Billion 240.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
โ‚น202.40 B-406.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel